Jiangsu GDK Biotechnology Co Ltd (688670) - Total Liabilities

Latest as of June 2025: CN¥238.19 Million CNY ≈ $34.85 Million USD

Based on the latest financial reports, Jiangsu GDK Biotechnology Co Ltd (688670) has total liabilities worth CN¥238.19 Million CNY (≈ $34.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Jiangsu GDK Biotechnology Co Ltd (688670) net asset momentum to track the company's year-over-year net asset growth rate.

Jiangsu GDK Biotechnology Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Jiangsu GDK Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Jiangsu GDK Biotechnology Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Jiangsu GDK Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu GDK Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Calamos LongShort Equity & Dynamic Income Trust NASDAQ:CPZ	USA	$344.59 Million
Putnam Managed Municipal Income Closed Fund NYSE:PMM	USA	$19.31 Million
Microbio Co Ltd TWO:4128	Taiwan	NT$2.13 Billion
Twin Disc Incorporated NASDAQ:TWIN	USA	$204.49 Million
Soulpower Acquisition Corporation NYSE:SOUL	USA	$13.99 Million
I-Sheng Electric Wire & Cable Co Ltd TW:6115	Taiwan	NT$2.96 Billion
SC Asset Corporation Public Company Limited BK:SC	Thailand	฿44.31 Billion
MBIA Inc NYSE:MBI	USA	$4.23 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Jiangsu GDK Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688670 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu GDK Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu GDK Biotechnology Co Ltd (2017–2024)

The table below shows the annual total liabilities of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥255.33 Million ≈ $37.36 Million	-1.99%
2023-12-31	CN¥260.52 Million ≈ $38.12 Million	-29.03%
2022-12-31	CN¥367.11 Million ≈ $53.72 Million	+25.24%
2021-12-31	CN¥293.12 Million ≈ $42.89 Million	-45.26%
2020-12-31	CN¥535.47 Million ≈ $78.36 Million	+5.89%
2019-12-31	CN¥505.68 Million ≈ $74.00 Million	+26.19%
2018-12-31	CN¥400.73 Million ≈ $58.64 Million	+11.50%
2017-12-31	CN¥359.39 Million ≈ $52.59 Million	--

About Jiangsu GDK Biotechnology Co Ltd

SHG:688670 China Biotechnology

Market Cap

$266.81 Million

CN¥1.82 Billion CNY

Market Cap Rank

#15404 Global

#4539 in China

Share Price

CN¥14.80

Change (1 day)

+0.07%

52-Week Range

CN¥12.97 - CN¥30.90

All Time High

CN¥75.07